Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: Maurice Winn who wrote (2490)	8/29/1998 7:00:00 PM
From: Shlepper	Read Replies (1) \| Respond to of 3702

Maurice, Seems like the FDA will have to move quickly on TNT approval. The FDA has actually expedited their review process over the last 5 years - they may still be a bit slower than we'd like, and they are overwhelmed with the explosion of drug applications coming through their doors - but with the results of these trials, they can move this along. Currently only patients with less than 60 days to live are being enrolled into their trials. I was wondering when TCLN can open up their protocol to less critical patients. By the way, thanks for your kind words - I think that Phil is probably a little touchy with all the red ink in the market in general and with TCLN. I have to put two daughters through college over the next 5 years, so I'm in a crunch as well, and can understand others frustrations. Thanks, Shlepper